Skip to main content
. 2023 Jun 29;24(13):10858. doi: 10.3390/ijms241310858

Table 1.

Incidence of each adverse event by cisplatin for HCC.

nausea 44% [124]
vomiting 44% [124]
myelosuppression 32% [125]
immunosuppression 18% [125]
hepatotoxicity 18% [126]
cardiotoxicity 6% [127]
nephrotoxicity 30–40% [84,85,86,90]
ototoxicity 20–70% [116]
neurotoxicity 19% to over 85% [117,118,119,120]